RU2005138922A -
METHOD FOR DAABUL PREVENTION AND TREATMENT OF ONCOLOGICAL DISEASES
- Google Patents
METHOD FOR DAABUL PREVENTION AND TREATMENT OF ONCOLOGICAL DISEASES
Download PDF
Info
Publication number
RU2005138922A
RU2005138922ARU2005138922/14ARU2005138922ARU2005138922ARU 2005138922 ARU2005138922 ARU 2005138922ARU 2005138922/14 ARU2005138922/14 ARU 2005138922/14ARU 2005138922 ARU2005138922 ARU 2005138922ARU 2005138922 ARU2005138922 ARU 2005138922A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Medicines Containing Plant Substances
(AREA)
Claims (4)
1. Способ профилактики и лечения онкологических заболеваний, заключающийся в приеме внутрь структурированной воды "Ренорм".1. A method for the prevention and treatment of cancer, which consists in the ingestion of structured Renorm water.2. Способ по п.1, отличающийся тем, что доза приема составляет 20-1500 мл в сутки.2. The method according to claim 1, characterized in that the dose is 20-1500 ml per day.3. Способ по п.1 или 2, отличающийся тем, что прием дозы производят в 3 приема на пустой желудок.3. The method according to claim 1 or 2, characterized in that the dose is taken in 3 divided doses on an empty stomach.4. Способ по п.1 или 2, отличающийся тем, что дополнительно используют химиотерапию и/или лучевую терапию.4. The method according to claim 1 or 2, characterized in that it further use chemotherapy and / or radiation therapy.
RU2005138922/14A2005-12-142005-12-14Daabul's method for normalization and stabilization of macrophage homeostasis in treatment of oncological diseases
RU2317820C2
(en)
Pharmaceutical composition for homeostasis stabilization and pathological processes arresting in organism, and injection dosage form of this composition
Use of fenofibrate or pharmaceutically acceptable salt thereof, orlistat and pharmaceutically acceptable carrier in the manufacture of medicaments for the treatment of obesity and pharmaceutical compositions containing them
UNIT DOSE FORM OF TEMOZOLOMIDE INCLUDING TEMOZOLOMIDE AND A PHARMACEUTICALLY ACCEPTABLE CARRIER; USES OF SUCH DOSAGE FORM TO TREAT A PATIENT WITH GLIOMA OR VARIOUS TYPES OF CANCER.